Viewing Study NCT00879359


Ignite Creation Date: 2025-12-24 @ 3:01 PM
Ignite Modification Date: 2025-12-26 @ 3:44 PM
Study NCT ID: NCT00879359
Status: COMPLETED
Last Update Posted: 2017-04-26
First Post: 2009-04-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
Sponsor: The Cleveland Clinic
Organization: